Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planTo cover taxesOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 11 of the 13 calendar months from Oct 2025 to Oct 2026: Dec 2025, Jan 2026, Feb 2026, Mar 2026, Apr 2026, May 2026, Jun 2026, Jul 2026, Aug 2026, Sep 2026 and Oct 2026.
- Largest single sale: $1.5M (29,652 shares) of Maze Therapeutics, Inc. on Mar 10, 2026. Filing
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Maze Therapeutics, Inc. (MAZE) | President, R&D & CMO | Jan 30, 2025 | Oct 2, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Oct 1, 2026, Maze Therapeutics, Inc.: sold 16,141 shares for $435K, under a disclosed plan; 16,141 shares acquired by exercising options. 1 filing: 1
- Sep 4, 2026, Maze Therapeutics, Inc.: sold 9,705 shares for $255K, under a disclosed plan. 1 filing: 1
- Sep 3, 2026, Maze Therapeutics, Inc.: sold 5,189 shares for $135K, to cover taxes. 1 filing: 1
- Sep 2, 2026, Maze Therapeutics, Inc.: sold 5,106 shares for $135K, to cover taxes. 1 filing: 1
- Sep 1, 2026, Maze Therapeutics, Inc.: sold 16,141 shares for $426K, under a disclosed plan; 16,141 shares acquired by exercising options; 20,000 shares vested. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.